Quadramet
Quadramet
Quadramet (pronounced: kwah-drah-met) is a radiopharmaceutical used in the treatment of pain caused by bone metastases. It is also known by its generic name, Samarium Sm 153 lexidronam.
Etymology
The name "Quadramet" is a brand name and does not have a known etymology. The generic name, Samarium Sm 153 lexidronam, is derived from the elements it contains: Samarium (Sm), which is a rare earth metal, and lexidronam, a chelating agent.
Usage
Quadramet is used to treat severe pain in patients with bone cancer. It works by delivering radiation directly to the cancer cells, which helps to alleviate pain. The drug is administered by injection.
Related Terms
- Radiopharmaceutical: A drug that contains radioactive substances which are used to treat certain conditions.
- Bone metastases: The spread of cancer cells from the original tumor to the bones.
- Samarium Sm 153 lexidronam: The generic name for Quadramet.
- Chelating agent: A substance that can form several bonds to a single metal ion.
Side Effects
Like all medications, Quadramet can cause side effects. These may include nausea, vomiting, and a decrease in blood cell counts. Patients should discuss potential side effects with their healthcare provider before starting treatment.
Precautions
Patients should inform their healthcare provider if they have kidney disease, are pregnant, or are breastfeeding before starting treatment with Quadramet. The drug can be harmful to the fetus and can pass into breast milk.
External links
- Medical encyclopedia article on Quadramet
- Wikipedia's article - Quadramet
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski